in Health care
USFDA advisers to weigh full nod for Eisai-Biogen Alzheimer’s drug Leqembi
US: The U.S. Food and Drug Administration (FDA) plans to hold a meeting of its outside experts in June to discuss full approval of the Alzheimer’s drug developed by Eisai Co Ltd and Biogen Inc, according to a federal filing on Monday. The drug, Leqembi was granted accelerated approval by the FDA in January for patients […] More
